NCT06374524View on ClinicalTrials.gov

Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

June 1, 2026

Conditions

Spontaneous Intracranial Hypotension

Interventions

PROCEDURE

greater occipital nerve block

Patients will receive an ultrasound-guided bilateral GONB (distal approach) of 5 mLs of injectate of bupivacaine 0.25% (5 mLs) + depomedrol 40 mg in 1 mL (3 mLs to each side).

All Listed Sponsors

lead

University Health Network, Toronto

OTHER

NCT06374524 - Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension | Biotech Hunter | Biotech Hunter